RX announced on 3 July that it has appointed Peter Lindsay as its new global chief strategy officer.
Lindsay (pictured left) will join the company on 4 September and will report to Hugh Jones, global CEO.
Commenting on the appointment, Jones says: “This appointment marks a new chapter in RX’s story. We know that to grow and expand our offering to customers, we need a senior and recognised strategic leader to help design the future which is exactly what Peter delivers.
He’s had tremendous success in driving operational excellence and business transformation for business and I couldn’t be more excited about the combination of customer-centricity and people-first leadership he will bring to RX in this role.”
Lindsay adds: “There’s never been a more exciting time to work in the exhibitions industry, and I look forward to partnering with teams at all levels to help our customers and our company find exciting new routes to growth.”
At RX, Lindsay will be responsible for strategy formulation and execution, corporate development activities including mergers and acquisitions, and other projects and strategic initiatives related to achieving profitable growth.
He will drive the company’s strategic projects, including strategic analysis, market intelligence, and advise on strategic, operational, tactical, and business development objectives.
